Background
2004 - 2005
Philippe Vandemoortele Belgium industrialist, entrepreneur and 2008 INSEAD Innovator Prize recipient discovers promising therapeutic medical technology invented and developed by internationally recognized Biophysicist Dr. Marc Vancraeyenest.
Vancraeyenest’s Technology exhibits the ability to exponentially speed human cellular recovery and regeneration in traumatized bodily tissue, skeletal and muscular structures. Equally significant, it demonstrates a unique ability to effectively influence neuroendocrine and central nervous system disorders. Vandemoortele and Vancraeyenest form partnership and Letec Nv. is formed. Strategies are developed to fully realize the benefits of the Technology with the goal of global medical mainstream adoption.
2006 - 2008
Letec nv becomes operational, assembling world-class team of professional research, development, industrialization and commercialization resources. Experts in biophysics, cellular biology, computer science, electrical and electronic engineering, manufacturing and new product development collaborate to optimize Letec’s innovative technological developments.
2009 - 2010
Design optimization and consolidation finalized for Letec Universal Cellular Technology (UCT). Initial UCT platform and systems are completed and integrated in prototype Eotron therapeutic medical device configurations.
Eotron positions for medical clinical trials in Western Europe and the United States.